Where to Buy Sermorelin, Ipamorelin: Vendor Comparison & Research Info

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.

Sermorelin and Ipamorelin

Perhaps the most targeted way to cause maximal growth hormone release is via the combination of sermorelin and ipamorelin. Sermorelin is a recently developed growth hormone releasing hormone (GHRH) analogue designed to preserve the positive effects of natural GHRH while avoiding some of the undesirable effects. Likewise, ipamorelin is the most specific, targeted analogue of ghrelin/growth hormone secretagogue currently known. When combined, these peptides act synergistically to cause extreme growth hormone release and thus maximize the benefits that GH has on muscle growth, brain health, heart health, and metabolism.

The targeted effects of sermorelin result in improved growth hormone effects on the heart. Research in pigs shows that sermorelin reduces cell death of cardiomyocytes, improves healing following cardiac injury, boosts the growth of collateral blood vessels, and reduces inflammation[1], [2]. A form of the ghrelin receptor has also recently been found in cardiac tissue where it has been shown to affect cardiac output. Administration of ghrelin and ghrelin analogues has been shown to reduce risk of abnormal heart beats and can improve healing following cardiac injury[3].

Sermorelin and ipamorelin have specific GH-related benefits that are more potent than what has been observed with other GH-releasing peptides. In addition to the heart benefits discussed above, research has shown sermorelin to benefit the central nervous system and improve sleep quality in animal models[4], [5]. Ipamorelin has been linked to bone health, insulin control in diabetes, and bowel motility (particularly following surgery)

Scientific Journal Author

Richard F. Walker, Ph.D, R.Ph, lead author of A better approach to management of adult-onset growth hormone insufficiency?”, received a BS in pharmacy from Rutgers University, a MS in Biochemistry from New Mexico State University and a PhD in a physiology from Rutgers University. He holds postdoctoral fellowships in neuroendocrinology and neuropharmacology at Duke University College of Medicine (Center for the Study of Aging and Human Development) and the University of California, Berkeley, respectively.

Richard F. Walker, Ph.D, R.Ph is being referenced as one of the leading scientists involved in the research and development of Sermorelin. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between  peptide Review Hub and this doctor. The purpose of citing the doctor is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying this peptide. Richard F. Walker, Ph.D, R.Ph is listed in [11] under the referenced citations.